Oramed’s Phase 2 Oral Insulin NASH Trial Reaches Over 50% Enrollment September 15, 2021 Press Releases
Oramed to Present at H.C. Wainwright 23rd Annual Global Investment Conference September 9, 2021 Press Releases
Oramed Reaches 25% Enrollment in Its Second of Two Concurrent Phase 3 Oral Insulin Trials August 24, 2021 Press Releases
Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and Metabolism August 16, 2021 Press Releases
Oravax to Present Keynote Talk on Oral COVID-19 Vaccine at the Arena International Vaccines Virtual Conference 2021 August 5, 2021 Press Releases
Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial July 21, 2021 Press Releases
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes June 22, 2021 Press Releases
